These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
200 related articles for article (PubMed ID: 31640190)
1. A Machine Learning-Based Prediction Platform for P-Glycoprotein Modulators and Its Validation by Molecular Docking. Kadioglu O; Efferth T Cells; 2019 Oct; 8(10):. PubMed ID: 31640190 [TBL] [Abstract][Full Text] [Related]
2. Homology Modeling of the Human P-glycoprotein (ABCB1) and Insights into Ligand Binding through Molecular Docking Studies. Mora Lagares L; Minovski N; Caballero Alfonso AY; Benfenati E; Wellens S; Culot M; Gosselet F; Novič M Int J Mol Sci; 2020 Jun; 21(11):. PubMed ID: 32517082 [TBL] [Abstract][Full Text] [Related]
3. Fingerprint-based in silico models for the prediction of P-glycoprotein substrates and inhibitors. Poongavanam V; Haider N; Ecker GF Bioorg Med Chem; 2012 Sep; 20(18):5388-95. PubMed ID: 22595422 [TBL] [Abstract][Full Text] [Related]
4. Predicting P-glycoprotein-mediated drug transport based on support vector machine and three-dimensional crystal structure of P-glycoprotein. Bikadi Z; Hazai I; Malik D; Jemnitz K; Veres Z; Hari P; Ni Z; Loo TW; Clarke DM; Hazai E; Mao Q PLoS One; 2011; 6(10):e25815. PubMed ID: 21991360 [TBL] [Abstract][Full Text] [Related]
5. Glabridin resensitizes p-glycoprotein-overexpressing multidrug-resistant cancer cells to conventional chemotherapeutic agents. Qian J; Xia M; Liu W; Li L; Yang J; Mei Y; Meng Q; Xie Y Eur J Pharmacol; 2019 Jun; 852():231-243. PubMed ID: 30959046 [TBL] [Abstract][Full Text] [Related]
6. Development of Simplified in Vitro P-Glycoprotein Substrate Assay and in Silico Prediction Models To Evaluate Transport Potential of P-Glycoprotein. Ohashi R; Watanabe R; Esaki T; Taniguchi T; Torimoto-Katori N; Watanabe T; Ogasawara Y; Takahashi T; Tsukimoto M; Mizuguchi K Mol Pharm; 2019 May; 16(5):1851-1863. PubMed ID: 30933526 [TBL] [Abstract][Full Text] [Related]
8. Modulation of the spacer in N,N-bis(alkanol)amine aryl ester heterodimers led to the discovery of a series of highly potent P-glycoprotein-based multidrug resistance (MDR) modulators. Dei S; Braconi L; Trezza A; Menicatti M; Contino M; Coronnello M; Chiaramonte N; Manetti D; Perrone MG; Romanelli MN; Udomtanakunchai C; Colabufo NA; Bartolucci G; Spiga O; Salerno M; Teodori E Eur J Med Chem; 2019 Jun; 172():71-94. PubMed ID: 30947123 [TBL] [Abstract][Full Text] [Related]
9. Caffeic Acid Attenuates Multi-Drug Resistance in Cancer Cells by Inhibiting Efflux Function of Human P-glycoprotein. Teng YN; Wang CCN; Liao WC; Lan YH; Hung CC Molecules; 2020 Jan; 25(2):. PubMed ID: 31936160 [No Abstract] [Full Text] [Related]
10. A High-Throughput Screen of a Library of Therapeutics Identifies Cytotoxic Substrates of P-glycoprotein. Lee TD; Lee OW; Brimacombe KR; Chen L; Guha R; Lusvarghi S; Tebase BG; Klumpp-Thomas C; Robey RW; Ambudkar SV; Shen M; Gottesman MM; Hall MD Mol Pharmacol; 2019 Nov; 96(5):629-640. PubMed ID: 31515284 [TBL] [Abstract][Full Text] [Related]
11. In silico model for P-glycoprotein substrate prediction: insights from molecular dynamics and in vitro studies. Prajapati R; Singh U; Patil A; Khomane KS; Bagul P; Bansal AK; Sangamwar AT J Comput Aided Mol Des; 2013 Apr; 27(4):347-63. PubMed ID: 23612916 [TBL] [Abstract][Full Text] [Related]
12. Overlapping ligand specificity of P-glycoprotein and serum alpha(1)-acid glycoprotein: evidences and potential implications. Zsila F Curr Drug Metab; 2007 Aug; 8(6):563-93. PubMed ID: 17691918 [TBL] [Abstract][Full Text] [Related]
14. Novel Heat Shock Protein 90 Inhibitors Suppress P-Glycoprotein Activity and Overcome Multidrug Resistance in Cancer Cells. Dinić J; Podolski-Renić A; Jovanović M; Musso L; Tsakovska I; Pajeva I; Dallavalle S; Pešić M Int J Mol Sci; 2019 Sep; 20(18):. PubMed ID: 31527404 [TBL] [Abstract][Full Text] [Related]
15. Prediction of promiscuous p-glycoprotein inhibition using a novel machine learning scheme. Leong MK; Chen HB; Shih YH PLoS One; 2012; 7(3):e33829. PubMed ID: 22439003 [TBL] [Abstract][Full Text] [Related]
16. P-glycoprotein--implications of metabolism of neoplastic cells and cancer therapy. Breier A; Barancík M; Sulová Z; Uhrík B Curr Cancer Drug Targets; 2005 Sep; 5(6):457-68. PubMed ID: 16178819 [TBL] [Abstract][Full Text] [Related]
17. A novel flavonoid from Fissistigma cupreonitens, 5‑hydroxy‑7,8‑dimethoxyflavanone, competitively inhibited the efflux function of human P-glycoprotein and reversed cancer multi-drug resistance. Teng YN; Lin KI; Lin YC; Thang TD; Lan YH; Hung CC Phytomedicine; 2021 May; 85():153528. PubMed ID: 33735724 [TBL] [Abstract][Full Text] [Related]
18. Development of a syngeneic in vivo tumor model and its use in evaluating a novel P-glycoprotein modulator, PGP-4008. Lee BD; French KJ; Zhuang Y; Smith CD Oncol Res; 2003; 14(1):49-60. PubMed ID: 14552591 [TBL] [Abstract][Full Text] [Related]
19. Reversal of multidrug resistance by Marsdenia tenacissima and its main active ingredients polyoxypregnanes. To KKW; Wu X; Yin C; Chai S; Yao S; Kadioglu O; Efferth T; Ye Y; Lin G J Ethnopharmacol; 2017 May; 203():110-119. PubMed ID: 28363522 [TBL] [Abstract][Full Text] [Related]
20. Screening dietary flavonoids for the reversal of P-glycoprotein-mediated multidrug resistance in cancer. Mohana S; Ganesan M; Agilan B; Karthikeyan R; Srithar G; Beaulah Mary R; Ananthakrishnan D; Velmurugan D; Rajendra Prasad N; Ambudkar SV Mol Biosyst; 2016 Jul; 12(8):2458-70. PubMed ID: 27216424 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]